Integrase inhibitor - PDFSEARCH.IO - Document Search Engine

Integrase inhibitor
Results: 31

#	Item
1	Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Alliso Add to Reading List Source URL: engelmanlab.med.harvard.edu Language: English - Date: 2013-05-21 15:55:24
2	Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio - ViiV Healthcare acquires exclusive global rights to HIV integrase inhibitor portfolio, including dolutegrav Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Intel Viiv Integrase inhibitors Organofluorides Pfizer Biology Pharmacology Dolutegravir Shionogi Pharmaceutical industry Pharmaceutical sciences ViiV Healthcare GlaxoSmithKline
3	Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference Positive Antiviral Responses Demonstrated in Interim 16 Week Analysis from SPRING-1 S Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:22 Medicine HIV/AIDS Cyclopropanes Integrase inhibitors Amides Lamivudine Zidovudine Antiretroviral drug GlaxoSmithKline Chemistry Organic chemistry Organofluorides
4	Data from the FLAMINGO Phase IIIb/IV Study of the Integrase Inhibitor Tivicay® (dolutegravir), Disclosed by ViiV Healthcare Osaka, Japan, September 13, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: I Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:11 Sulfonamides Medicine Carbamates Darunavir HIV/AIDS Antiretroviral drug ViiV Healthcare Zidovudine Integrase inhibitor Protease inhibitors Chemistry Biology
5	Interim Results from SAILING Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, March 7, Shionogi & Co., Ltd. (Head Office: Osaka; Preside Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Organic chemistry Medicine Amides Merck Oxadiazoles Raltegravir Integrase Dolutegravir ViiV Healthcare Integrase inhibitors Chemistry Organofluorides
6	ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2015-01-27 14:49:56 Integrase inhibitors Abacavir Cyclopropanes Purines Antiretroviral drug HIV/AIDS Lamivudine Reverse-transcriptase inhibitor ViiV Healthcare Biology Chemistry Organofluorides
7	PDF Document Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:09 ViiV Healthcare Intel Viiv Prescription Drug User Fee Act Shionogi Integrase inhibitor Food and Drug Administration Integrase Pharmaceutical sciences Pharmacology Clinical research
8	Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor Phase III Treatment-naïve and Treatment-experienced Trials Underway for S/GSK1349572 (‘572) Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:21 Health Medicine Integrase inhibitors GlaxoSmithKline ViiV Healthcare Lamivudine Pfizer Integrase Raltegravir Organofluorides Chemistry HIV/AIDS
9	Data from VIKING-3 Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, November 14, Shionogi & Co., Ltd. (Head Office: Osaka; President & C Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:18 Enzymes Integrase Microbiology Virology ViiV Healthcare Intel Viiv Shionogi Dolutegravir HIV Integrase inhibitors Biology Organofluorides
10	PDF Document Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2015-01-14 06:19:30 Integrase inhibitors Gilead Sciences Cyclopropanes Carbamates Antiretroviral drug Efavirenz Raltegravir Fixed-dose combination Reverse-transcriptase inhibitor Chemistry Organic chemistry Organofluorides

UPDATE